GEORGE B ABERCROMBIE Insider Trading
Get free email notifications about insider trading for GEORGE B ABERCROMBIE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GEORGE B ABERCROMBIE. GEORGE B ABERCROMBIE is a Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and an CHIEF EXECUTIVE OFFICER in Brickell Biotech, Inc. ($VICL) and a Sr. VP & Chief Comm. Officer in Innoviva, Inc. ($THRX) and a Director in INSPIRE PHARMACEUTICALS INC ($ISPH).
Address: C/O INSPIRE PHARMACEUTICALS, INC. 4222 EMPEROR BLVD., SUITE 200 DURHAM 27703 NC
Companies in which GEORGE B ABERCROMBIE is an Insider
BIOCRYST PHARMACEUTICALS INC
Trading Symbol: BCRXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GEORGE B ABERCROMBIE: Director
Holdings: 3,000 shares
Current Value: $17,010
Latest Transaction: May 12 2021
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Brickell Biotech, Inc.
Trading Symbol: VICLIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GEORGE B ABERCROMBIE: CHIEF EXECUTIVE OFFICER
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 19 2020
$VICL Market Capitalization: $24.86M
$VICL Previous Close: $2.13
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Innoviva, Inc.
Trading Symbol: THRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GEORGE B ABERCROMBIE: Sr. VP & Chief Comm. Officer
Holdings: 293,479 shares
Latest Transaction: Aug 22 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INSPIRE PHARMACEUTICALS INC
Trading Symbol: ISPHIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GEORGE B ABERCROMBIE: Director
Holdings: 1,099 shares
Latest Transaction: Jun 07 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of GEORGE B ABERCROMBIE
Sentiment: All, BCRX, VICL, THRX, ISPH
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 12 2021 | BCRX | BIOCRYST PHARMACEU ... | ABERCROMBIE GEORGE B | Director | Sell | S | 12.70 | 7,000 | 88,900 | 3,000 | 10 K to 3 K (-70.00 %) |
Feb 19 2020 | VICL | Brickell Biotech, ... | ABERCROMBIE GEORGE B | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.16 | 8,764 | 10,166 | 8,764 | |
Feb 19 2020 | VICL | Brickell Biotech, ... | ABERCROMBIE GEORGE B | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.16 | 2,167 | 2,514 | 2,167 | |
May 31 2019 | BCRX | BIOCRYST PHARMACEU ... | ABERCROMBIE GEORGE B | Director | Option Exercise | A | 2.91 | 30,000 | 87,300 | 30,000 | |
Aug 22 2018 | THRX | Innoviva, Inc. | ABERCROMBIE GEORGE B | Sr. VP & Chief Comm ... | Sell | S | 14.11 | 8,000 | 112,840 | 285,479 | 293.5 K to 285.5 K (-2.73 %) |
Aug 22 2018 | THRX | Innoviva, Inc. | ABERCROMBIE GEORGE B | Sr. VP & Chief Comm ... | Payment of Exercise | F | 14.08 | 5,680 | 79,974 | 293,479 | 299.2 K to 293.5 K (-1.90 %) |
Jun 22 2018 | BCRX | BIOCRYST PHARMACEU ... | ABERCROMBIE GEORGE B | Director | Option Exercise | A | 6.09 | 30,000 | 182,700 | 30,000 |